These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16132229)

  • 1. Nucleotide binding domains of human CFTR: a structural classification of critical residues and disease-causing mutations.
    Eudes R; Lehn P; Férec C; Mornon JP; Callebaut I
    Cell Mol Life Sci; 2005 Sep; 62(18):2112-23. PubMed ID: 16132229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
    Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
    Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide-binding domains of human cystic fibrosis transmembrane conductance regulator: detailed sequence analysis and three-dimensional modeling of the heterodimer.
    Callebaut I; Eudes R; Mornon JP; Lehn P
    Cell Mol Life Sci; 2004 Jan; 61(2):230-42. PubMed ID: 14745501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR.
    Jih KY; Li M; Hwang TC; Bompadre SG
    J Physiol; 2011 Jun; 589(Pt 11):2719-31. PubMed ID: 21486785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations.
    Vernon RM; Chong PA; Lin H; Yang Z; Zhou Q; Aleksandrov AA; Dawson JE; Riordan JR; Brouillette CG; Thibodeau PH; Forman-Kay JD
    J Biol Chem; 2017 Aug; 292(34):14147-14164. PubMed ID: 28655774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-relevant mutations alter amino acid co-evolution networks in the second nucleotide binding domain of CFTR.
    Ivey G; Youker RT
    PLoS One; 2020; 15(1):e0227668. PubMed ID: 31978131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interactions between nucleotide binding domains and membrane spanning domains in cystic fibrosis transmembrane regulator: A molecular dynamic study.
    Belmonte L; Moran O
    Biochimie; 2015 Apr; 111():19-29. PubMed ID: 25640670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
    J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain-domain associations in cystic fibrosis transmembrane conductance regulator.
    Wang W; He Z; O'Shaughnessy TJ; Rux J; Reenstra WW
    Am J Physiol Cell Physiol; 2002 May; 282(5):C1170-80. PubMed ID: 11940532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains.
    Wang W; Bernard K; Li G; Kirk KL
    J Biol Chem; 2007 Feb; 282(7):4533-4544. PubMed ID: 17178710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the degenerated interfacial ATP binding site improves the function of disease-related mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels.
    Tsai MF; Jih KY; Shimizu H; Li M; Hwang TC
    J Biol Chem; 2010 Nov; 285(48):37663-71. PubMed ID: 20861014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel.
    Tsai MF; Li M; Hwang TC
    J Gen Physiol; 2010 May; 135(5):399-414. PubMed ID: 20421370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
    Csanády L; Chan KW; Nairn AC; Gadsby DC
    J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
    Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
    Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
    Chen JH; Cai Z; Sheppard DN
    J Biol Chem; 2009 Dec; 284(51):35495-506. PubMed ID: 19837660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.